G protein-coupled receptors (GPCR) are seven transmembrane helix proteins that couple binding of extracellular ligands to conformational changes and activation of intracellular G proteins, GPCR kinases, and arrestins. Constitutively active mutants are ubiquitously found among GPCRs and increase the inherent basal activity of the receptor, which often correlates with a pathological outcome. Here, we have used the M257Y 6.40 constitutively active mutant of the photoreceptor rhodopsin in combination with the specific binding of a C-terminal fragment from the G protein alpha subunit (GαCT) to trap a light activated state for crystallization. The structure of the M257Y/GαCT complex contains the agonist all-trans-retinal covalently bound to the native binding pocket and resembles the G protein binding metarhodopsin-II conformation obtained by the natural activation mechanism; i.e., illumination of the prebound chromophore 11-cis-retinal. The structure further suggests a molecular basis for the constitutive activity of 6.40 substitutions and the strong effect of the introduced tyrosine based on specific interactions with Y223 5.58 in helix 5, Y306 7.53 of the NPxxY motif and R135 3.50 of the E(D)RY motif, highly conserved residues of the G protein binding site.constitutive activity | GPCRs | light-activated | rhodopsin T he more than 800 G protein-coupled receptors (GPCRs) in a typical eukaryotic genome allow signaling between cells and tissues and provide an important link to our environment as the principal receptors for our senses of taste, smell, and vision. Rhodopsin, the dim-light sensor in rod photoreceptor cells, is the prototypical receptor to study the molecular mechanisms of GPCR activation. This is due mainly to a wealth of biophysical and spectroscopic methods that take advantage of the covalently bound chromophore retinal. The possibility to purify rhodopsin directly from its native membrane furthermore facilitated its crystallization and structure determination. Comparison of structures with spectroscopic and biochemical data allowed the accurate attribution to specific states and to track the sequence of events during activation (1). This unique framework includes structures of the ground state from native (2, 3) and thermostabilized recombinant protein (4), several metastable intermediates (5, 6) with bound all-trans-retinal and an activated form of the apoprotein opsin (7). Opsin has also been solved in complex with a peptide resembling the C-terminus of the G protein alpha subunit (GαCT), which provided the first molecular insights into how the G protein binds the active receptor (8). Recently, active state structures that contain the retinal agonist have been solved using two different approaches. In one, the mutation E113Q 3.28 (9) was incorporated into rhodopsin to neutralize the counterion of the retinal Schiff base (10) preventing dissociation of retinal. In the other, opsin crystals were grown and then back-soaked with all-trans-retinal (11). Both structures share many features that are expecte...